CancerCare announces co-payment assistance for pancreatic cancer patients

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

CANCERCARE announced the availability of co-payment assistance for pancreatic cancer patients through the CancerCare Co-Payment Assistance Foundation.

People receiving assistance from CCAF also have access to the full array of CancerCare services, including counseling, support groups, resource referrals, publications, education and financial assistance with treatment-related expenses such as transportation and child care.

“We are thrilled to provide this crucial co-payment assistance to people coping with a pancreatic cancer diagnosis,” said Patricia Goldsmith, CEO of CancerCare. “Pancreatic cancer can be an especially challenging diagnosis to treat, and the CancerCare Co-Payment Assistance Foundation is committed to easing the financial burden so that patients can focus on managing their diagnosis and maintaining quality of life during treatment.”

YOU MAY BE INTERESTED IN

By law, the Food and Drug Administration is required to determine whether a drug, device, biologic, or medical device is “safe and effective.” But the FDA determination does not control whether the Centers for Medicare & Medicaid Services will pay for it.  To satisfy CMS, medical products and services must be “reasonable and necessary,” meaning...

As a radiation oncologist, I am struck by how often the decisive variable in lung cancer is not the sophistication of our therapy, but the timing of our encounter with the disease.  The American Cancer Society projects 618,120 cancer deaths in the United States in 2025, with lung cancer remaining as the single largest contributor,...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login